by Moon Hyewon
Published 13 May.2026 17:19(KST)
On May 13, HLB Pharm announced that it has decided to conduct a rights offering followed by a public offering for forfeited shares in order to raise approximately 120 billion won for facility funds and other purposes.
A total of 10,762,332 new common shares will be issued at 11,150 won per share.